News and Insights

The latest news and insights from Genoa Healthcare.

  • Behavioral Health
  • Clinical Insights
  • Treatment

Cobenfy™: 5 things to know about the new schizophrenia treatment option

Want to learn more about Cobenfy? Save your seat for Genoa’s webinar on Oct. 9 here. Staying on top of new medication therapy options for your consumers living with schizophrenia...

  • Oct 1st, 2024
  • Clinical Insights
  • HIV
  • Treatment

Pharmacist-prescribed PrEP and PEP pilot expands pharmacy scope of practice

By Jennifer Finocchiaro, PharmD, AAHIVE The role of the pharmacist has changed significantly over the years, expanding from medication dispensing and counseling to providing direct patient care. As the pharmacy...

  • Sep 10th, 2024
  • Behavioral Health
  • Clinical Insights
  • Treatment

Understanding Tardive Dyskinesia: What you need to know

Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually. Wondering what this means for the people you serve? Genoa...

  • Apr 11th, 2024
  • Behavioral Health
  • Clinical Insights
  • Treatment

March 2024 drug trend report

Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview and connect with your local pharmacy team to...

  • Mar 13th, 2024
  • Behavioral Health
  • Clinical Insights
  • Treatment

February 2024 drug trend report

Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview and connect with your local pharmacy team to...

  • Feb 1st, 2024
  • Behavioral Health
  • Clinical Insights
  • Treatment

Uzedy™: Long-acting injection for the treatment of schizophrenia

Learn more about this new treatment option for adults living with schizophrenia Genoa is here to help keep you informed on the latest in behavioral health medications. Read on to...

  • Jan 31st, 2024
  • Behavioral Health
  • Clinical Insights
  • Treatment

Brixadi®: 3 things to know about the buprenorphine treatment option

Staying on top of new medication therapy options for your consumers living with opioid use disorder (OUD) can be difficult. Learn how the new FDA-approved medication, Brixadi®, can help support...

  • Dec 6th, 2023
  • Behavioral Health
  • Clinical Insights
  • Treatment

November 2023 drug trend report

Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview of the latest and connect with your local...

  • Nov 1st, 2023
  • Behavioral Health
  • Clinical Insights
  • Treatment

3 Trends to follow this flu season

According to the CDC, flu season runs rampant from October through May.1 Looking to keep the people you serve safe during the 2023-2024 flu season? Keep these three trends on...

  • Oct 4th, 2023
  • Behavioral Health
  • Clinical Insights
  • Treatment

September 2023 drug trend report

Genoa Healthcare’s latest drug trend report highlights information on new medication launches as well as noteworthy drug shortages currently in market. Brand name drug launches* Brixadi™ Zurzuvae™ (zuranolone) Generic drug...

  • Sep 1st, 2023